Stockholders’ Deficit and Stock-Based Compensation - Schedule of Options Activity (Details) - 2022 Omnibus Plan - Options to purchase common stock - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2026	Dec. 31, 2025
Shares
Balances at the beginning (in shares)	4,074
Granted (in shares)	59,938
Exercised (in shares)	0
Forfeited (in shares)	(73)
Balances at the ending (in shares)	63,939	4,074
Weighted Average Exercise Price
Balances at the beginning (in dollars per share)	$ 337.58
Granted (in dollars per share)	3.32
Exercised (in dollars per share)	0
Forfeited (in dollars per share)	261.16
Balances at the ending (in dollars per share)	$ 24.29	$ 337.58
Weighted Average Contractual Life (in years)
Balances at the ending (in years)	9 years 10 months 9 days	8 years 3 months 7 days
Aggregate Intrinsic Value (in thousands)
Outstanding at beginning of period	$ 0
Granted	0
Exercised	0
Forfeited	0
Outstanding at end of period	$ 0	$ 0
Vested and exercisable at period end (in shares)	2,632
Vested and exercisable at period end (in dollars per share)	$ 436.89
Vested and exercisable at period end (in years)	7 years 6 months 18 days
Vested and exercisable at end of period (intrinsic value)	$ 0